A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

The record

StatusCompleted

PhasePhase 1

Taking part29

StartedAug 2011

UpdatedOct 7, 2014

Conditions

Where3

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Daytona Beach, Florida, United States
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Honolulu, Hawaii, United States
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Dallas, Texas, United States

Clareo Health | A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes